From: MTA1 promotes metastasis of MPM via suppression of E-cadherin
Characteristics | All patients | MTA1 expression | P | ||
---|---|---|---|---|---|
Low | High | χ2 | |||
N | 65 | 25 | 40 | ||
Sex | 0.455 | 0.559 | |||
Male | 35 | 12 | 23 | ||
Female | 30 | 13 | 17 | ||
Age (years) | 0.842 | 0.040 | |||
<60 | 27 | 10 | 17 | ||
≥60 | 38 | 15 | 23 | ||
Histology | 0.038 | 6.524 | |||
Epithelioid | 20 | 13 | 7 | ||
Sarcomatoid | 25 | 7 | 18 | ||
Biphasic | 20 | 5 | 15 | ||
TNM stagea | 0.003 | 8.990 | |||
I/II | 29 | 17 | 12 | ||
III/IV | 36 | 8 | 28 | ||
Lymph node Metastasis | 0.001 | 11.714 | |||
Yes | 38 | 8 | 30 | ||
No | 27 | 17 | 10 | ||
Distant Metastasis | <0.001 | 14.562 | |||
Yes | 35 | 6 | 29 | ||
No | 30 | 19 | 11 |